Show simple item record

dc.creatorValle Turrillas, Jaionees_ES
dc.creatorSolano Goñi, Cristinaes_ES
dc.creatorGarcía Martínez, Begoñaes_ES
dc.creatorToledo Arana, Alejandroes_ES
dc.creatorLasa Uzcudun, Íñigoes_ES
dc.date.accessioned2016-11-04T15:28:56Z
dc.date.available2016-11-04T15:28:56Z
dc.date.issued2013
dc.identifier.issn0966-842X (Print)
dc.identifier.issn1878-4380 (Electronic)
dc.identifier.urihttps://hdl.handle.net/2454/22576
dc.description.abstractBiofilm development is recognized as a major virulence factor underlying most chronic bacterial infections. When a biofilm community is established, planktonic cells growing in the surroundings of a tissue switch to a sessile lifestyle and start producing a biofilm matrix. The initial steps of in vivo biofilm development are poorly characterized and difficult to assess experimentally. A great amount of in vitro evidence has shown that accumulation of high levels of cyclic dinucleotides (c-di-NMPs) is the most prevalent hallmark governing the initiation of biofilm development by bacteria. As mentioned above, recent studies also link detection of c-di-NMPs by host cells with the activation of a type I interferon immune response against bacterial infections. We discuss here c-di-NMP signaling and the host immune response in the context of the initial steps of in vivo biofilm development.en
dc.description.sponsorshipJ. Valle was supported by Spanish Ministry of Science and Innovation ‘Ramón y Cajal’ contract. Work in the Laboratory of Microbial Biofilms is funded by the Spanish Ministry of Economy and Competitiveness grants BIO2011-30503-C02-02, AGL2011-23954, and BFU2011-23222, as well as by ERA-NET Pathogenomics (PIM2010EPA-00606) and grants from the Departamento de Innovación (IIQ14066.RI1 and IIM13329.RI1) and Departamento de Salud (Resolución 1312/2010), Gobierno de Navarra.en
dc.format.mimetypeapplication/pdfen
dc.language.isoengen
dc.publisherElsevier (Cell Press)en
dc.relation.ispartofTrends in Microbiology, August 2013, Vol. 21, No. 8en
dc.rights© 2013 Elsevier Ltd. All rights reserved.en
dc.subjectBiofilmsen
dc.subjectChronic infectionsen
dc.subjectInnate immune responseen
dc.subjectc-di-GMPen
dc.subjectSTINGen
dc.subjectPAMPsen
dc.subjectType I interferonen
dc.subjectcGASen
dc.titleBiofilm switch and immune response determinants at early stages of infectionen
dc.typeArtículo / Artikuluaes
dc.typeinfo:eu-repo/semantics/articleen
dc.contributor.departmentIdAB - Instituto de Agrobiotecnología / Agrobioteknologiako Institutuaes
dc.rights.accessRightsAcceso abierto / Sarbide irekiaes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessen
dc.identifier.doi10.1016/j.tim.2013.05.008
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/6PN/BIO2011-30503en
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/6PN/AGL2011-23954en
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/6PN/BFU2011-23222en
dc.relation.publisherversionhttps://dx.doi.org/10.1016/j.tim.2013.05.008
dc.type.versionVersión aceptada / Onetsi den bertsioaes
dc.type.versioninfo:eu-repo/semantics/acceptedVersionen
dc.contributor.funderGobierno de Navarra / Nafarroako Gobernua: IIQ14066.RI1
dc.contributor.funderGobierno de Navarra / Nafarroako Gobernua: IIM13329.RI1
dc.contributor.funderGobierno de Navarra / Nafarroako Gobernua: 1312/2010


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record